Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • OmniActive Health eyes...

    OmniActive Health eyes more takeovers, to invest Rs 150 crore

    Written by Ruby Khatun Khatun Published On 2017-11-13T14:03:59+05:30  |  Updated On 18 Aug 2021 1:58 PM IST

    New Delhi: OmniActive Health Technologies, a leading nutraceutical company, is looking at more strategic acquisitions in domestic and foreign markets and has drawn up capital expenditure plans of around Rs 150 crore in the next three years.


    Building on an M&A (mergers and acquisitions) strategy to grow inorganically, the company has recently acquired leading health and nutrition active natural ingredient player, Indfrag.


    "We are now looking at more strategic acquisitions in the domestic as well as foreign markets in the space of marketing and technology," OmniActive MD Sanjaya Mariwala told here.


    The company's strength lies in its ability to leverage science and technology to meet consumer demand and rigorous quality standards for today's dietary supplement market.


    In the last 18 months, OmniActive completed 12 human clinical trials with healthy population across its portfolio of branded ingredients, providing unique, science-based claims to expand consumer offerings.


    "We are continuously making the investment in R&D and expansion programmes. We are doing a capex of Rs 30-35 crore per annum and going forward, looking at the investment of around Rs 150 crore for expansion of more nutraceutical products," Mariwala said.


    The company hopes to double its turnover to Rs 1,000 crore in three years, he said.


    The Mumbai-based OmniActive supplies ingredients to several global clients, including large healthcare, nutrition, and consumer staples companies. It has the presence in six countries -- the US, Canada, the UK, France, China, and Japan.


    With state of the art R&D centers in Pune, Mumbai and New Jersey, OmniActive deploy an array of sophisticated manufacturing technologies in extraction, purification, isolation, and delivery of nutritional actives.


    The company is looking at launching more supplement products for the population of 30-45 years of age group and women.


    The country's nutraceutical market is estimated at USD 500-600 million and is growing 15-20 percent on a CAGR (compound annual growth rate) basis.


    With the recent acquisition of Indfrag, OmniActive is now set to launch a new business venture in the v-commerce domain that aims to provide products to the Internet-savvy younger group, Mariwala added.


    Virtual commerce, or v-commerce, is a kind of application, service, or product feature that helps entities execute strategies and design websites for e-commerce.

    acquisitionscapexhealthIndfragInvestmentmergersnutraceuticalsOmniActive HealthOmniActive Health TechnologiesSanjaya MariwalatakeoversVirtual commerce
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok